Botanix Pharmaceuticals Limited (BOT.AX)
Makes prescription skin gels to treat excessive sweating, acne, and other dermatological conditions
0.02-0.10%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-86.9%
The outlook
BOT.AX is trading near its 52-week lows at $0.019, well below both its 50- and 200-day moving averages, signaling a weak near-term trend. Analyst coverage shows a stark disconnect: the average price target implies significant upside, though the overall StockGlow sentiment leans bearish. The stock remains highly speculative and illiquid at current levels.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Price targetAvg target +2479% vs current price
Analyst price target
~12-month · 3 analysts0.49average target+2478.9% vs now
Now 0.02
Low 0.14High 1.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$51.7M
52-wk high
0.17
52-wk low
0.02
50-day avg
0.02
200-day avg
0.07
Trailing P/E
—